The Jewish General Hospital (JGH), a member facility of the West-Central Montreal Health Authority (CIUSSS), together with Auger Groupe Conseil Inc. (AGC) and Medtronic Canada ULC ― a subsidiary of Medtronic plc (NYSE:MDT) ― have pioneered the first application of the Microsoft HoloLens for use in real-time, extended reality (XR) clinical support of a minimally invasive heart procedure.
| Platform Significantly Reduces Travel as a Barrier to Patient Care MONTREAL, June 21, 2021 /CNW/ - The Jewish General Hospital (JGH), a member facility of the West-Central Montreal Health Authority (CIUSSS), together with Auger Groupe Conseil Inc. (AGC) and Medtronic Canada ULC ― a subsidiary of Medtronic plc (NYSE:MDT) ― have pioneered the first application of the Microsoft HoloLens for use in real-time, extended reality (XR) clinical support of a minimally invasive heart procedure. On March 15th, 2021, this novel partnership completed the first end-to-end remotely guided transcatheter aortic valve implant/replacement (TAVI/TAVR) – a minimally invasive procedure to replace a heart valve. Dr. Sam Radhakrishnan, the proctor or teaching specialist in Toronto, was able to remotely guide the JGH TAVI team of Dr. Ali Abualsaud, Dr. Nathan Messas, and Dr. Emmanuel Moss through the procedure in real time at the JGH in Montreal, using the intra-operative extended reality platform. It is comprised of three key elements:
“We think of it as bringing the operating room to the surgical specialist. Rather than coordinating resources to bring a specialist to another hospital for training, now we can greatly simplify the process, which can help improve the timeliness of patient care, especially in an emergency,” said Dr. Lawrence Rudski, director of the Azrieli Heart Center. “There are significant advantages to using a real-time, extended-reality system for both the proctor and the clinician on the receiving end, such as having the same view – which is almost better than being in the same, often crowded, room. In addition, this platform has the flexibility to be expanded to many other types of procedures.” During the initial peak of the pandemic in spring 2020, the JGH was designated as a lead COVID-19 treatment site. The ensuing staffing challenges, combined with travel restrictions, required effective and remote training solutions. In collaboration with Quebec engineering firm AGC, the JGH piloted the use of the Microsoft HoloLens to help train and redeploy staff. “We chose to work with Microsoft mainly because of the HoloLens 2’s unmatched performance and in part because of the security offered by their encryption design,” said Marcel Lafontaine, CEO of AGC. “We are very proud of our work in combining the mixed reality experience of voice, video and a 3D overlay with no lag time. This is a unique plug-and-play solution, and we’re very excited to see it deployed in such an impactful way for clinicians, and ultimately for patients.” The initial success of this project led to developing remote support in a complex clinical pathway and connectivity to medical imaging with the help of leading medical device company Medtronic. “We are thrilled to be able to contribute our expertise to this unique partnership and are looking forward to seeing this collaboration extend to other clinical pathways,” said Richard Paré, regional business director of the CardioVascular Portfolio at Medtronic Canada. “This innovative platform can enable health systems to optimize surgical resources and scheduling, while protecting staff, during the pandemic but also afterwards as they shift their focus to addressing the surgical backlog.” The partnership is currently planning additional applications in the field of cardiovascular medicine and in other areas. This project is supported by OROT Innovation Hub at the JGH. Microsoft and HoloLens are trademarks of the Microsoft group of companies. About CIUSSS West-Central Montreal The area covered by this network is home to approximately 345,000 people, who are served by more than 30 member facilities. Included are one of Montreal’s leading hospitals (the Jewish General Hospital) and an interlocking array of three specialized hospitals, five CLSCs, two rehabilitation centres, six long-term care sites, two-day centres and several affiliated research facilities. Treatment and care are provided by a staff of more than 12,000, and over 600 doctors. About Auger Groupe Conseil Inc. About Medtronic Canada ULC Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the U.S. Securities and Exchange Commission. Actual results may differ materially from anticipated results. SOURCE Medtronic Canada ULC | ||
Company Codes: NYSE:MDT |
